GlobeNewswire 12/11/2025 Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Sub...
GlobeNewswire 12/11/2025 LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
GlobeNewswire 12/11/2025 Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
GlobeNewswire 07/11/2025 ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting...
GlobeNewswire 07/11/2025 Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC an...
GlobeNewswire 07/11/2025 Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immu...
GlobeNewswire 07/11/2025 Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercializatio...
GlobeNewswire 06/11/2025 Genmab Announces Financial Results for the Nine Months of 2025
GlobeNewswire 06/11/2025 Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire 05/11/2025 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 04/11/2025 Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life...
GlobeNewswire 03/11/2025 Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
GlobeNewswire 03/11/2025 Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer
GlobeNewswire 31/10/2025 Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Mo...
GlobeNewswire 30/10/2025 Association of Corporate Counsel (ACC) Honors Outstanding In-house Professionals at 2025 ACC Annual...
GlobeNewswire 30/10/2025 Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients wi...
GlobeNewswire 28/10/2025 ThoughtSpot Doubles User Adoption On Surging Agentic Analytics Demand
GlobeNewswire 28/10/2025 Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
GlobeNewswire 28/10/2025 Zag Bio™ Launches with $80 Million Financing to Advance Thymus-targeted Medicines for Autoimmune Dis...
GlobeNewswire 22/10/2025 ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Dr...
GlobeNewswire 22/10/2025 Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
GlobeNewswire 20/10/2025 CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer
GlobeNewswire 20/10/2025 ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (AS...
GlobeNewswire 17/10/2025 Royalty Pharma Declares Fourth Quarter 2025 Dividend
GlobeNewswire 16/10/2025 Galapagos Announces Appointment of Fred Blakeslee as General Counsel